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Serum lactate dehydrogenase as early marker  
of posterior reversible encephalopathy syndrome: 
keep your eyes open
Posterior reversible encephalopathy syndrome 
(PRES) is associated with many clinical conditions 
including pre-eclampsia/eclampsia. So far, this 
association has been explained mainly in terms of 
blood pressure variation, failure of cerebral 
vasculature autoregulatory mechanism and brain 
oedema1,2. However, it is well known the main 
mechanism in pre-eclampsia is the endothelial 
activation and injury with systemic consequences, 
i.e. vasoconstriction, instable blood pressure and 
abnormal response to vasopressors3. 
L-lactate dehydrogenase (LDH) is an intra- 
cellular enzyme that converts lactic acid to 
pyruvic acid, elevated levels indicating cellular 
death or damage4. LDH isoenzymes are present 
in many body tissues such as brain, kidney, liver, 
lung, myocardium, spleen, erythrocytes, leucocytes 
and platelets5. Tissue levels of these isoenzymes 
are about 500 fold higher than those normally 
found in serum; leakage of the enzymes from 
a damaged tissue can increase the serum LDH 
levels5. Endothelial injuries or irregularities of 
the endothelial walls lead to a disruption or a 
morphological disturbance of red blood cells 
and to an increased release of LDH into the 
serum6,7. Moreover in eclampsia, overwhelming 
inflammatory response, placental-maternal immune 
reaction and anti-endothelial cell antibodies 
are responsible for the endothelial activation/
injury, resulting in platelet adhesion/degranulation, 
haemolysis and LDH elevation, protein/fluid 
leakage and systemic oedema3.
Schwartz et al first reported the correlation 
between increased LDH levels and risk of PRES 
in individuals with pre-eclampsia/eclampsia. Indeed, 
in some cases, increased LDH value was the 
only abnormal laboratory parameter before the 
onset of symptoms6. Demirtas et al also reported 
raised LDH levels in pre-eclamptic/eclamptic 
patients with abnormal magnetic resonance 
imaging findings suggestive of PRES7. Finally, 
Finocchi et al showed abnormally high LDH 
levels in eclamptic subjects who developed PRES, 
even before the onset of the symptoms8. 
We reviewed the clinical charts of the obstetric 
patients with PRES admitted at our intensive care 
unit during a period of 12 months. Analysis of 
the data (Table 1) revealed overall increased 
LDH levels (995.6±440.6 IU/l; n.v.227 to 450 IU/l) 
at presentation, including patients with normal 
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blood pressure values. Although we failed to 
find a clear association between LDH values and 
severity of brain oedema, all subjects showed 
abnormally high LDH levels already three 
(628.6±95.8 IU/l) or two (660.16±118.3 IU/l) 
days before the onset of PRES. Notably, the 
peak of LDH increase did not necessarily 
correspond to the symptoms presentation. In fact 
LDH increase already even some days before 
PRES would further support the role of 
asymptomatic or subclinical endothelial dysfunction/
injury as the primum movens in both hyper- 
tensive and normotensive patients. The endothelial 
damage probably impairs the mechanism of 
vasorelaxation, which depends on normal endo-
thelium function and that is responsible for a zone 
of vasoconstriction/vasodilatation also in the 
cerebral capillary bed, thus resulting in a 
blood-brain barrier breakdown10. The next step 
of this breakdown mechanism is the extravasation 
of fluid in resulting in vasogenic brain oedema. 
The pathogenetic mechanisms of PRES remain 
controversial. Opposing theories are the 
hypertension/hyperperfusion and vasoconstriction/
hypoperfusion3. We believe that behind these 
two opposing theories there is a common 
denominator, i.e. endothelial damage that can 
explain both hypotheses. 
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